カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の月経前症候群治療薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Premenstrual Syndrome Medicine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19562）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19562
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：73
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の月経前症候群治療薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

月経前症候群治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の月経前症候群治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

月経前症候群治療薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・PH-80PMD、エストロゲン、プロゲステロン、その他

用途別セグメントは次のように区分されます。
・在宅医療、病院、診療所

世界の月経前症候群治療薬市場の主要な市場プレーヤーは以下のとおりです。
・Asarina Pharma AB、Pherin Pharmaceuticals Inc

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、月経前症候群治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な月経前症候群治療薬メーカーの企業概要、2019年～2022年までの月経前症候群治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な月経前症候群治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別月経前症候群治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの月経前症候群治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での月経前症候群治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および月経前症候群治療薬の産業チェーンを掲載しています。
・第13、14、15章では、月経前症候群治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 月経前症候群治療薬の概要
- 種類別分析（2017年vs2021年vs2028年）：PH-80PMD、エストロゲン、プロゲステロン、その他
- 用途別分析（2017年vs2021年vs2028年）：在宅医療、病院、診療所
- 世界の月経前症候群治療薬市場規模・予測
- 世界の月経前症候群治療薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Asarina Pharma AB、Pherin Pharmaceuticals Inc
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：PH-80PMD、エストロゲン、プロゲステロン、その他
・用途別分析2017年-2028年：在宅医療、病院、診療所
・月経前症候群治療薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・月経前症候群治療薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・月経前症候群治療薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・月経前症候群治療薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・月経前症候群治療薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Premenstrual Syndrome Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Premenstrual Syndrome Medicine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Home Care accounting for % of the Premenstrual Syndrome Medicine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While PH-80PMD segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Premenstrual Syndrome Medicine include Asarina Pharma AB, Pherin Pharmaceuticals Inc, , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Premenstrual Syndrome Medicine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
PH-80PMD
Estrogen
Progesterone
Others
Market segment by Application can be divided into
Home Care
Hospital
Clinic
The key market players for global Premenstrual Syndrome Medicine market are listed below:
Asarina Pharma AB
Pherin Pharmaceuticals Inc
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Premenstrual Syndrome Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Premenstrual Syndrome Medicine, with price, sales, revenue and global market share of Premenstrual Syndrome Medicine from 2019 to 2022.
Chapter 3, the Premenstrual Syndrome Medicine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Premenstrual Syndrome Medicine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Premenstrual Syndrome Medicine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Premenstrual Syndrome Medicine.
Chapter 13, 14, and 15, to describe Premenstrual Syndrome Medicine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Premenstrual Syndrome Medicine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Premenstrual Syndrome Medicine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 PH-80PMD
1.2.3 Estrogen
1.2.4 Progesterone
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Premenstrual Syndrome Medicine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Home Care
1.3.3 Hospital
1.3.4 Clinic
1.4 Global Premenstrual Syndrome Medicine Market Size & Forecast
1.4.1 Global Premenstrual Syndrome Medicine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Premenstrual Syndrome Medicine Sales in Volume (2017-2028)
1.4.3 Global Premenstrual Syndrome Medicine Price (2017-2028)
1.5 Global Premenstrual Syndrome Medicine Production Capacity Analysis
1.5.1 Global Premenstrual Syndrome Medicine Total Production Capacity (2017-2028)
1.5.2 Global Premenstrual Syndrome Medicine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Premenstrual Syndrome Medicine Market Drivers
1.6.2 Premenstrual Syndrome Medicine Market Restraints
1.6.3 Premenstrual Syndrome Medicine Trends Analysis
2 Manufacturers Profiles
2.1 Asarina Pharma AB
2.1.1 Asarina Pharma AB Details
2.1.2 Asarina Pharma AB Major Business
2.1.3 Asarina Pharma AB Premenstrual Syndrome Medicine Product and Services
2.1.4 Asarina Pharma AB Premenstrual Syndrome Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pherin Pharmaceuticals Inc
2.2.1 Pherin Pharmaceuticals Inc Details
2.2.2 Pherin Pharmaceuticals Inc Major Business
2.2.3 Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Product and Services
2.2.4 Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Premenstrual Syndrome Medicine Breakdown Data by Manufacturer
3.1 Global Premenstrual Syndrome Medicine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Premenstrual Syndrome Medicine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Premenstrual Syndrome Medicine
3.4 Market Concentration Rate
3.4.1 Top 3 Premenstrual Syndrome Medicine Manufacturer Market Share in 2021
3.4.2 Top 6 Premenstrual Syndrome Medicine Manufacturer Market Share in 2021
3.5 Global Premenstrual Syndrome Medicine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Premenstrual Syndrome Medicine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Premenstrual Syndrome Medicine Market Size by Region
4.1.1 Global Premenstrual Syndrome Medicine Sales in Volume by Region (2017-2028)
4.1.2 Global Premenstrual Syndrome Medicine Revenue by Region (2017-2028)
4.2 North America Premenstrual Syndrome Medicine Revenue (2017-2028)
4.3 Europe Premenstrual Syndrome Medicine Revenue (2017-2028)
4.4 Asia-Pacific Premenstrual Syndrome Medicine Revenue (2017-2028)
4.5 South America Premenstrual Syndrome Medicine Revenue (2017-2028)
4.6 Middle East and Africa Premenstrual Syndrome Medicine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Premenstrual Syndrome Medicine Sales in Volume by Type (2017-2028)
5.2 Global Premenstrual Syndrome Medicine Revenue by Type (2017-2028)
5.3 Global Premenstrual Syndrome Medicine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Premenstrual Syndrome Medicine Sales in Volume by Application (2017-2028)
6.2 Global Premenstrual Syndrome Medicine Revenue by Application (2017-2028)
6.3 Global Premenstrual Syndrome Medicine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Premenstrual Syndrome Medicine Sales by Type (2017-2028)
7.2 North America Premenstrual Syndrome Medicine Sales by Application (2017-2028)
7.3 North America Premenstrual Syndrome Medicine Market Size by Country
7.3.1 North America Premenstrual Syndrome Medicine Sales in Volume by Country (2017-2028)
7.3.2 North America Premenstrual Syndrome Medicine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Premenstrual Syndrome Medicine Sales by Type (2017-2028)
8.2 Europe Premenstrual Syndrome Medicine Sales by Application (2017-2028)
8.3 Europe Premenstrual Syndrome Medicine Market Size by Country
8.3.1 Europe Premenstrual Syndrome Medicine Sales in Volume by Country (2017-2028)
8.3.2 Europe Premenstrual Syndrome Medicine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Premenstrual Syndrome Medicine Sales by Type (2017-2028)
9.2 Asia-Pacific Premenstrual Syndrome Medicine Sales by Application (2017-2028)
9.3 Asia-Pacific Premenstrual Syndrome Medicine Market Size by Region
9.3.1 Asia-Pacific Premenstrual Syndrome Medicine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Premenstrual Syndrome Medicine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Premenstrual Syndrome Medicine Sales by Type (2017-2028)
10.2 South America Premenstrual Syndrome Medicine Sales by Application (2017-2028)
10.3 South America Premenstrual Syndrome Medicine Market Size by Country
10.3.1 South America Premenstrual Syndrome Medicine Sales in Volume by Country (2017-2028)
10.3.2 South America Premenstrual Syndrome Medicine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Premenstrual Syndrome Medicine Sales by Type (2017-2028)
11.2 Middle East & Africa Premenstrual Syndrome Medicine Sales by Application (2017-2028)
11.3 Middle East & Africa Premenstrual Syndrome Medicine Market Size by Country
11.3.1 Middle East & Africa Premenstrual Syndrome Medicine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Premenstrual Syndrome Medicine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Premenstrual Syndrome Medicine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Premenstrual Syndrome Medicine
12.3 Premenstrual Syndrome Medicine Production Process
12.4 Premenstrual Syndrome Medicine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Premenstrual Syndrome Medicine Typical Distributors
13.3 Premenstrual Syndrome Medicine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Premenstrual Syndrome Medicine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Premenstrual Syndrome Medicine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Asarina Pharma AB Basic Information, Manufacturing Base and Competitors
Table 4. Asarina Pharma AB Major Business
Table 5. Asarina Pharma AB Premenstrual Syndrome Medicine Product and Services
Table 6. Asarina Pharma AB Premenstrual Syndrome Medicine Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pherin Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 8. Pherin Pharmaceuticals Inc Major Business
Table 9. Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Product and Services
Table 10. Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Global Premenstrual Syndrome Medicine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)
Table 12. Global Premenstrual Syndrome Medicine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 13. Market Position of Manufacturers in Premenstrual Syndrome Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 14. Global Premenstrual Syndrome Medicine Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 15. Head Office and Premenstrual Syndrome Medicine Production Site of Key Manufacturer
Table 16. Premenstrual Syndrome Medicine New Entrant and Capacity Expansion Plans
Table 17. Premenstrual Syndrome Medicine Mergers & Acquisitions in the Past Five Years
Table 18. Global Premenstrual Syndrome Medicine Sales by Region (2017-2022) & (K Pcs)
Table 19. Global Premenstrual Syndrome Medicine Sales by Region (2023-2028) & (K Pcs)
Table 20. Global Premenstrual Syndrome Medicine Revenue by Region (2017-2022) & (USD Million)
Table 21. Global Premenstrual Syndrome Medicine Revenue by Region (2023-2028) & (USD Million)
Table 22. Global Premenstrual Syndrome Medicine Sales by Type (2017-2022) & (K Pcs)
Table 23. Global Premenstrual Syndrome Medicine Sales by Type (2023-2028) & (K Pcs)
Table 24. Global Premenstrual Syndrome Medicine Revenue by Type (2017-2022) & (USD Million)
Table 25. Global Premenstrual Syndrome Medicine Revenue by Type (2023-2028) & (USD Million)
Table 26. Global Premenstrual Syndrome Medicine Price by Type (2017-2022) & (USD/Pcs)
Table 27. Global Premenstrual Syndrome Medicine Price by Type (2023-2028) & (USD/Pcs)
Table 28. Global Premenstrual Syndrome Medicine Sales by Application (2017-2022) & (K Pcs)
Table 29. Global Premenstrual Syndrome Medicine Sales by Application (2023-2028) & (K Pcs)
Table 30. Global Premenstrual Syndrome Medicine Revenue by Application (2017-2022) & (USD Million)
Table 31. Global Premenstrual Syndrome Medicine Revenue by Application (2023-2028) & (USD Million)
Table 32. Global Premenstrual Syndrome Medicine Price by Application (2017-2022) & (USD/Pcs)
Table 33. Global Premenstrual Syndrome Medicine Price by Application (2023-2028) & (USD/Pcs)
Table 34. North America Premenstrual Syndrome Medicine Sales by Country (2017-2022) & (K Pcs)
Table 35. North America Premenstrual Syndrome Medicine Sales by Country (2023-2028) & (K Pcs)
Table 36. North America Premenstrual Syndrome Medicine Revenue by Country (2017-2022) & (USD Million)
Table 37. North America Premenstrual Syndrome Medicine Revenue by Country (2023-2028) & (USD Million)
Table 38. North America Premenstrual Syndrome Medicine Sales by Type (2017-2022) & (K Pcs)
Table 39. North America Premenstrual Syndrome Medicine Sales by Type (2023-2028) & (K Pcs)
Table 40. North America Premenstrual Syndrome Medicine Sales by Application (2017-2022) & (K Pcs)
Table 41. North America Premenstrual Syndrome Medicine Sales by Application (2023-2028) & (K Pcs)
Table 42. Europe Premenstrual Syndrome Medicine Sales by Country (2017-2022) & (K Pcs)
Table 43. Europe Premenstrual Syndrome Medicine Sales by Country (2023-2028) & (K Pcs)
Table 44. Europe Premenstrual Syndrome Medicine Revenue by Country (2017-2022) & (USD Million)
Table 45. Europe Premenstrual Syndrome Medicine Revenue by Country (2023-2028) & (USD Million)
Table 46. Europe Premenstrual Syndrome Medicine Sales by Type (2017-2022) & (K Pcs)
Table 47. Europe Premenstrual Syndrome Medicine Sales by Type (2023-2028) & (K Pcs)
Table 48. Europe Premenstrual Syndrome Medicine Sales by Application (2017-2022) & (K Pcs)
Table 49. Europe Premenstrual Syndrome Medicine Sales by Application (2023-2028) & (K Pcs)
Table 50. Asia-Pacific Premenstrual Syndrome Medicine Sales by Region (2017-2022) & (K Pcs)
Table 51. Asia-Pacific Premenstrual Syndrome Medicine Sales by Region (2023-2028) & (K Pcs)
Table 52. Asia-Pacific Premenstrual Syndrome Medicine Revenue by Region (2017-2022) & (USD Million)
Table 53. Asia-Pacific Premenstrual Syndrome Medicine Revenue by Region (2023-2028) & (USD Million)
Table 54. Asia-Pacific Premenstrual Syndrome Medicine Sales by Type (2017-2022) & (K Pcs)
Table 55. Asia-Pacific Premenstrual Syndrome Medicine Sales by Type (2023-2028) & (K Pcs)
Table 56. Asia-Pacific Premenstrual Syndrome Medicine Sales by Application (2017-2022) & (K Pcs)
Table 57. Asia-Pacific Premenstrual Syndrome Medicine Sales by Application (2023-2028) & (K Pcs)
Table 58. South America Premenstrual Syndrome Medicine Sales by Country (2017-2022) & (K Pcs)
Table 59. South America Premenstrual Syndrome Medicine Sales by Country (2023-2028) & (K Pcs)
Table 60. South America Premenstrual Syndrome Medicine Revenue by Country (2017-2022) & (USD Million)
Table 61. South America Premenstrual Syndrome Medicine Revenue by Country (2023-2028) & (USD Million)
Table 62. South America Premenstrual Syndrome Medicine Sales by Type (2017-2022) & (K Pcs)
Table 63. South America Premenstrual Syndrome Medicine Sales by Type (2023-2028) & (K Pcs)
Table 64. South America Premenstrual Syndrome Medicine Sales by Application (2017-2022) & (K Pcs)
Table 65. South America Premenstrual Syndrome Medicine Sales by Application (2023-2028) & (K Pcs)
Table 66. Middle East & Africa Premenstrual Syndrome Medicine Sales by Region (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Premenstrual Syndrome Medicine Sales by Region (2023-2028) & (K Pcs)
Table 68. Middle East & Africa Premenstrual Syndrome Medicine Revenue by Region (2017-2022) & (USD Million)
Table 69. Middle East & Africa Premenstrual Syndrome Medicine Revenue by Region (2023-2028) & (USD Million)
Table 70. Middle East & Africa Premenstrual Syndrome Medicine Sales by Type (2017-2022) & (K Pcs)
Table 71. Middle East & Africa Premenstrual Syndrome Medicine Sales by Type (2023-2028) & (K Pcs)
Table 72. Middle East & Africa Premenstrual Syndrome Medicine Sales by Application (2017-2022) & (K Pcs)
Table 73. Middle East & Africa Premenstrual Syndrome Medicine Sales by Application (2023-2028) & (K Pcs)
Table 74. Premenstrual Syndrome Medicine Raw Material
Table 75. Key Manufacturers of Premenstrual Syndrome Medicine Raw Materials
Table 76. Direct Channel Pros & Cons
Table 77. Indirect Channel Pros & Cons
Table 78. Premenstrual Syndrome Medicine Typical Distributors
Table 79. Premenstrual Syndrome Medicine Typical Customers
List of Figures
Figure 1. Premenstrual Syndrome Medicine Picture
Figure 2. Global Premenstrual Syndrome Medicine Revenue Market Share by Type in 2021
Figure 3. PH-80PMD
Figure 4. Estrogen
Figure 5. Progesterone
Figure 6. Others
Figure 7. Global Premenstrual Syndrome Medicine Revenue Market Share by Application in 2021
Figure 8. Home Care
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Global Premenstrual Syndrome Medicine Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028
Figure 12. Global Premenstrual Syndrome Medicine Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Premenstrual Syndrome Medicine Sales (2017-2028) & (K Pcs)
Figure 14. Global Premenstrual Syndrome Medicine Price (2017-2028) & (USD/Pcs)
Figure 15. Global Premenstrual Syndrome Medicine Production Capacity (2017-2028) & (K Pcs)
Figure 16. Global Premenstrual Syndrome Medicine Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Premenstrual Syndrome Medicine Market Drivers
Figure 18. Premenstrual Syndrome Medicine Market Restraints
Figure 19. Premenstrual Syndrome Medicine Market Trends
Figure 20. Global Premenstrual Syndrome Medicine Sales Market Share by Manufacturer in 2021
Figure 21. Global Premenstrual Syndrome Medicine Revenue Market Share by Manufacturer in 2021
Figure 22. Premenstrual Syndrome Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Premenstrual Syndrome Medicine Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Premenstrual Syndrome Medicine Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Premenstrual Syndrome Medicine Sales Market Share by Region (2017-2028)
Figure 26. Global Premenstrual Syndrome Medicine Revenue Market Share by Region (2017-2028)
Figure 27. North America Premenstrual Syndrome Medicine Revenue (2017-2028) & (USD Million)
Figure 28. Europe Premenstrual Syndrome Medicine Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Premenstrual Syndrome Medicine Revenue (2017-2028) & (USD Million)
Figure 30. South America Premenstrual Syndrome Medicine Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Premenstrual Syndrome Medicine Revenue (2017-2028) & (USD Million)
Figure 32. Global Premenstrual Syndrome Medicine Sales Market Share by Type (2017-2028)
Figure 33. Global Premenstrual Syndrome Medicine Revenue Market Share by Type (2017-2028)
Figure 34. Global Premenstrual Syndrome Medicine Price by Type (2017-2028) & (USD/Pcs)
Figure 35. Global Premenstrual Syndrome Medicine Sales Market Share by Application (2017-2028)
Figure 36. Global Premenstrual Syndrome Medicine Revenue Market Share by Application (2017-2028)
Figure 37. Global Premenstrual Syndrome Medicine Price by Application (2017-2028) & (USD/Pcs)
Figure 38. North America Premenstrual Syndrome Medicine Sales Market Share by Type (2017-2028)
Figure 39. North America Premenstrual Syndrome Medicine Sales Market Share by Application (2017-2028)
Figure 40. North America Premenstrual Syndrome Medicine Sales Market Share by Country (2017-2028)
Figure 41. North America Premenstrual Syndrome Medicine Revenue Market Share by Country (2017-2028)
Figure 42. United States Premenstrual Syndrome Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Premenstrual Syndrome Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Premenstrual Syndrome Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Premenstrual Syndrome Medicine Sales Market Share by Type (2017-2028)
Figure 46. Europe Premenstrual Syndrome Medicine Sales Market Share by Application (2017-2028)
Figure 47. Europe Premenstrual Syndrome Medicine Sales Market Share by Country (2017-2028)
Figure 48. Europe Premenstrual Syndrome Medicine Revenue Market Share by Country (2017-2028)
Figure 49. Germany Premenstrual Syndrome Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Premenstrual Syndrome Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Premenstrual Syndrome Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Premenstrual Syndrome Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Premenstrual Syndrome Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Premenstrual Syndrome Medicine Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Premenstrual Syndrome Medicine Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Premenstrual Syndrome Medicine Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Premenstrual Syndrome Medicine Revenue Market Share by Region (2017-2028)
Figure 58. China Premenstrual Syndrome Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Premenstrual Syndrome Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Premenstrual Syndrome Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Premenstrual Syndrome Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Premenstrual Syndrome Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Premenstrual Syndrome Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Premenstrual Syndrome Medicine Sales Market Share by Type (2017-2028)
Figure 65. South America Premenstrual Syndrome Medicine Sales Market Share by Application (2017-2028)
Figure 66. South America Premenstrual Syndrome Medicine Sales Market Share by Country (2017-2028)
Figure 67. South America Premenstrual Syndrome Medicine Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Premenstrual Syndrome Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Premenstrual Syndrome Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Premenstrual Syndrome Medicine Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Premenstrual Syndrome Medicine Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Premenstrual Syndrome Medicine Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Premenstrual Syndrome Medicine Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Premenstrual Syndrome Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Premenstrual Syndrome Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Premenstrual Syndrome Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Premenstrual Syndrome Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Premenstrual Syndrome Medicine in 2021
Figure 79. Manufacturing Process Analysis of Premenstrual Syndrome Medicine
Figure 80. Premenstrual Syndrome Medicine Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 過敏性腸症候群治療薬のグローバル市場展望 2023年-2029年：IBS-D薬、IBS-C薬、その他
  • メンクス症候群のグローバル市場展望 2023年-2029年：遺伝子治療、銅注射療法
  • 世界のハンター症候群治療市場2022年：市場規模予測（～2028年）
  • 世界のコンパートメント症候群モニタリング装置市場2022年：市場規模予測（～2028年）
  • 世界の乾燥症候群治療薬市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19562 )"世界の月経前症候群治療薬市場2022年：市場規模予測（～2028年）" (英文：Global Premenstrual Syndrome Medicine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。